Boston Scientific (BSX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 12.92% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 30.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.80% |
| Mar 31, 2026 | 98.96% |
| Dec 31, 2025 | 18.94% |
| Sep 30, 2025 | 60.98% |
| Jun 30, 2025 | 145.99% |
| Mar 31, 2025 | 36.16% |
| Dec 31, 2024 | 11.88% |
| Sep 30, 2024 | -7.13% |
| Jun 30, 2024 | 24.14% |
| Mar 31, 2024 | 65.00% |
| Dec 31, 2023 | 300.79% |
| Sep 30, 2023 | 190.23% |
| Jun 30, 2023 | 6.10% |
| Mar 31, 2023 | 209.28% |
| Dec 31, 2022 | 57.50% |
| Sep 30, 2022 | -57.04% |
| Jun 30, 2022 | 43.02% |
| Mar 31, 2022 | -70.34% |
| Dec 31, 2021 | -59.18% |
| Sep 30, 2021 | 339.64% |